Hospira a Pfizer Company Recall: 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 m
Hospira a Pfizer Company Recall: 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 m is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Hospira a Pfizer Company; Product: 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL), Rx Only, Mfd by Hos
| Recalling firm | Hospira a Pfizer Company |
|---|---|
| Product | 8.4% Sodium Bicarbonate Inj., USP 50 mL Single-dose, 50 mEq (1 mEq/mL) 4.2 grams (84 mg/mL), Rx Only, Mfd by Hospira, INC, Lake Forest, IL 60045 USA, NDC: 0409-6625-02 |
| Reason for recall | Lack of Sterility Assurance |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | U.S. (including Puerto Rico), Dutch Antilles, Barbados, Canada, Philippines, Kuwait, and Singapore |
| Recall initiated | 20170615 |
| Recall number | D-1047-2017 |
| Category | drug |
| State | NC |
| Country | United States |
$29/mo
Try RecallGuard →